logo-loader
viewSerco Group

Serco inks £135mln in contract extensions with Peterborough and Lincolnshire councils

The new extensions, worth £105mln and £30mln respectively, involve the provision of customer services, IT, and payroll functions

Serco and Lincolnshire council logos
The contract with Lincolnshire council will now run until at least 2022

Serco Group PLC (LON:SRP) has inked around £135mln in contract extensions with Peterborough City Council and Lincolnshire County Council to continue providing frontline and back-office services.

The FTSE 250 outsourcing firm said it had been supporting Peterborough council since 2011 as part of a 10-year partnership providing services including customer services, business support services, shared transactional services, transactional HR and payroll, procurement and business transformation.

READ: Serco upgraded to ‘Sector Perform’ by RBC as it now sees 2019 forecasts as “achievable”

The ten-year extension is until 2021 and carries a value of around £105mln.

The firm added that it had signed a two-year extension with Lincolnshire local authority worth a total of £30mln. The contract included the provision of customer services, financial services, IT services and transactional HR and payroll.

With the extension, these services will continue until at least 2022.

Rupert Soames, chief executive of Serco, said the firm had met its key performance indicators across both contracts and had “worked extremely hard to deliver improvements in these services”.

In early trading Tuesday, Serco shares were up 1.6% at 85.5p.

Quick facts: Serco Group

Price: 149.4 GBX

LSE:SRP
Market: LSE
Market Cap: £1.83 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Summit Therapeutics' Glyn Edwards talks US$50mln backing and ridinilazole...

Summit Therapeutics PLC's (LON:SUMM, NASDAQ:SMMT) CEO Glyn Edwards sat down with Proactive London's Andrew Scott following the news of a US$50mln funding deal with biotech billionaire Bob Duggan. The investment will help get the company’s next-generation antibiotic through phase III clinical...

5 hours, 59 minutes ago

2 min read